Successful imatinib mesylate therapy for acquired von Willebrand syndrome in chronic myelogenous leukemia

Leuk Res. 2009 Dec;33(12):1723-4. doi: 10.1016/j.leukres.2009.05.011. Epub 2009 Jul 5.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Benzamides
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Male
  • Middle Aged
  • Piperazines / therapeutic use*
  • Pyrimidines / therapeutic use*
  • von Willebrand Diseases / drug therapy*

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate